Effects of Nitric Oxide for Inhalation in Myocardial Infarction Size

A phase 2 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 250 participants.

Also called NCT01398384

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; double masking; primary purpose treatment
Phase
Phase 2
Enrolled
  • 250 participants (enrolled count) (from the registry)
Sponsor
Registry
  • NCT NCT01398384
Other papers using this trial's data
  • Nitric oxide for inhalation in ST-elevation myocardial infarction (NOMI): a multicentre, double-blind, randomized controlled trial European heart journal, 2018-08-01 DOI, PubMed 29800130

Courtesy of the U.S. National Library of Medicine.

Start date
(registry gives no type) (from the registry)
Primary completion
(actual) (from the registry)
Completion
(actual) (from the registry)
Countries
Belgium, Hungary, Poland (from the registry)
Registry status
  • Completed (from the registry)

Technical summary

Registry record NCT01398384. Randomized; double masking; primary purpose treatment. Start 2010-10 (registry gives no type); primary completion 2014-05 (actual). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
Effects of Nitric Oxide for Inhalation in Myocardial Infarction Size
Acronym
NOMI
Condition
Acute Myocardial Infarction
Intervention (Drug)
Nitric Oxide
Intervention (Drug)
MI size at 48-72 hours
Lead sponsor
Universitaire Ziekenhuizen KU Leuven (class: other)

Record details

Record id
cardio:ct-nct01398384
Content hash
aa957c470520640ef7e8a450c4b37b318f1fce850c2e05b4c29e16ce0a2bf093